298 related articles for article (PubMed ID: 29264794)
21. [Analysis of genetic polymorphisms of thiopurine S-methyltransferase (TPMT) in Mexican pediatric patients with cancer].
Moreno-Guerrero SS; Ramírez-Pacheco A; Dorantes-Acosta EM; Medina-Sanson A
Rev Invest Clin; 2013; 65(2):156-64. PubMed ID: 23844534
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms of the thiopurine S-methyltransferase gene among the Libyan population.
Zeglam HB; Benhamer A; Aboud A; Rtemi H; Mattardi M; Saleh SS; Bashein A; Enattah N
Libyan J Med; 2015; 10(1):27053. PubMed ID: 25819542
[TBL] [Abstract][Full Text] [Related]
23. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations.
Collie-Duguid ES; Pritchard SC; Powrie RH; Sludden J; Collier DA; Li T; McLeod HL
Pharmacogenetics; 1999 Feb; 9(1):37-42. PubMed ID: 10208641
[TBL] [Abstract][Full Text] [Related]
24. The frequency and distribution of thiopurine S-methyltransferase alleles in south Iranian population.
Moini M; Ghaderi F; Sagheb MM; Tavasolli AR; Azarpira N; Darai M; Geramizadeh B
Mol Biol Rep; 2012 Apr; 39(4):4581-7. PubMed ID: 21938428
[TBL] [Abstract][Full Text] [Related]
25. The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves' disease in a Mexican population.
López-Cano DJ; Cadena-Sandoval D; Beltrán-Ramírez O; Barbosa-Cobos RE; Sánchez-Muñoz F; Amezcua-Guerra LM; Juárez-Vicuña Y; Aguilera-Cartas MC; Moreno J; Bautista-Olvera J; Valencia-Pacheco G; López-Villanueva RF; Ramírez-Bello J
Inflamm Res; 2017 Sep; 66(9):775-781. PubMed ID: 28500376
[TBL] [Abstract][Full Text] [Related]
26. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
Cao Q; Zhu Q; Shang Y; Gao M; Si J
Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
[TBL] [Abstract][Full Text] [Related]
27. [Effect of genetic polymorphism of TPMT and NUDT15 on the tolerance of 6-mercaptopurine therapy in adult acute lymphoblastic leukemia].
Hao QS; Wang Z; Fang QY; Gong XY; Liu KQ; Li Y; Wei H; Wang Y; Li QH; Wang M; Tian Z; Wang JX; Mi YC
Zhonghua Xue Ye Xue Za Zhi; 2021 Nov; 42(11):911-916. PubMed ID: 35045652
[No Abstract] [Full Text] [Related]
28. Development of a rapid clinical TPMT genotyping assay.
Burchard PR; Abou Tayoun AN; Lefferts JA; Lewis LD; Tsongalis GJ; Cervinski MA
Clin Biochem; 2014 Oct; 47(15):126-9. PubMed ID: 25093923
[TBL] [Abstract][Full Text] [Related]
29. Pyrosequencing of TPMT alleles in a general Swedish population and in patients with inflammatory bowel disease.
Haglund S; Lindqvist M; Almer S; Peterson C; Taipalensuu J
Clin Chem; 2004 Feb; 50(2):288-95. PubMed ID: 14656901
[TBL] [Abstract][Full Text] [Related]
30. Frequency of thiopurine S-methyltransferase mutant alleles in indigenous and admixed Guatemalan patients with acute lymphoblastic leukemia.
Garrido C; Santizo VG; Müllers P; Soriano DR; Avila GB; Dean M; Jimenez-Morales S
Med Oncol; 2013 Mar; 30(1):474. PubMed ID: 23377985
[TBL] [Abstract][Full Text] [Related]
31. Identification of thiopurine methyltransferase (TPMT) polymorphisms cannot predict myelosuppression in systemic lupus erythematosus patients taking azathioprine.
Naughton MA; Battaglia E; O'Brien S; Walport MJ; Botto M
Rheumatology (Oxford); 1999 Jul; 38(7):640-4. PubMed ID: 10461478
[TBL] [Abstract][Full Text] [Related]
32. Frequency of thiopurine S-methyltransferase (TPMT) alleles in southeast Iranian population.
Bahari A; Hashemi M; Bari Z; Moazeni-Roodi A; Kaykhaei MA; Narouie B
Nucleosides Nucleotides Nucleic Acids; 2010 Mar; 29(3):237-44. PubMed ID: 20408054
[TBL] [Abstract][Full Text] [Related]
33. Thiopurine methyltransferase alleles in British and Ghanaian populations.
Ameyaw MM; Collie-Duguid ES; Powrie RH; Ofori-Adjei D; McLeod HL
Hum Mol Genet; 1999 Feb; 8(2):367-70. PubMed ID: 9931345
[TBL] [Abstract][Full Text] [Related]
34. Azathioprine dose tailoring based on pharmacogenetic information: Insights of clinical implementation.
Díaz-Villamarín X; Fernández-Varón E; Rojas Romero MC; Callejas-Rubio JL; Cabeza-Barrera J; Rodríguez-Nogales A; Gálvez J; Morón R
Biomed Pharmacother; 2023 Dec; 168():115706. PubMed ID: 37857254
[TBL] [Abstract][Full Text] [Related]
35. Genetic analysis of thiopurine methyltransferase polymorphism in a Japanese population.
Hiratsuka M; Inoue T; Omori F; Agatsuma Y; Mizugaki M
Mutat Res; 2000 Mar; 448(1):91-5. PubMed ID: 10751626
[TBL] [Abstract][Full Text] [Related]
36. PTPN22 polymorphisms, but not R620W, were associated with the genetic susceptibility of systemic lupus erythematosus and rheumatoid arthritis in a Chinese Han population.
Tang L; Wang Y; Zheng S; Bao M; Zhang Q; Li J
Hum Immunol; 2016 Aug; 77(8):692-698. PubMed ID: 27166176
[TBL] [Abstract][Full Text] [Related]
37. The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.
Kurzawski M; Dziewanowski K; Gawrońska-Szklarz B; Domański L; Droździk M
Ther Drug Monit; 2005 Aug; 27(4):435-41. PubMed ID: 16044099
[TBL] [Abstract][Full Text] [Related]
38. Efficient screening method of the thiopurine methyltransferase polymorphisms for patients considering taking thiopurine drugs in a Chinese Han population in Henan Province (central China).
Zhang LR; Song DK; Zhang W; Zhao J; Jia LJ; Xing DL
Clin Chim Acta; 2007 Feb; 376(1-2):45-51. PubMed ID: 16952345
[TBL] [Abstract][Full Text] [Related]
39. Influence of the TNFSF4 rs1234315 polymorphism in the susceptibility to systemic lupus erythematosus and rheumatoid arthritis.
Xu J; He Y; Wang J; Li X; Huang L; Li S; Qin X
Hum Immunol; 2019 Apr; 80(4):270-275. PubMed ID: 30468820
[TBL] [Abstract][Full Text] [Related]
40. TLR4 and TLR9 polymorphisms are not associated with either rheumatoid arthritis or systemic lupus erythematosus in Mexican patients.
Aranda-Uribe IS; López-Vázquez JC; Barbosa-Cobos RE; Ramírez-Bello J
Mol Biol Rep; 2021 Apr; 48(4):3561-3565. PubMed ID: 33939072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
